This AI-enabled biotech stock nearly doubled on Wednesday: here’s why

Evaxion Biotech (NASDAQ: EVAX) opened nearly 100% up on Wednesday after announcing an “expanded commitment” to developing novel cancer vaccines. Evaxion Biotech stock is rallying today The tailored vaccines will tap on artificial intelligence to identify tumour antigens known broadly as Endogenous Retroviruses (ERVs). Such an AI-Immunology™ powered discovery of novel therapeutics targets will make […]